Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Ettinger, DS; Wood, DE; Aisner, DL; Akerley, W; Bauman, J; Chirieac, LR; D'Amico, TA; DeCamp, MM; Dilling, TJ; Dobelbower, M; Doebele, RC ...
Published in: J Natl Compr Canc Netw
April 2017
This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezolizumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2017
Volume
15
Issue
4
Start / End Page
504 / 535
Location
United States
Related Subject Headings
- Treatment Outcome
- Recurrence
- Prognosis
- Oncology & Carcinogenesis
- Neoplasm Metastasis
- Molecular Targeted Therapy
- Lung Neoplasms
- Immunotherapy
- Humans
- Disease Management
Citation
APA
Chicago
ICMJE
MLA
NLM
Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J., Chirieac, L. R., … Hughes, M. (2017). Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 15(4), 504–535. https://doi.org/10.6004/jnccn.2017.0050
Ettinger, David S., Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica Bauman, Lucian R. Chirieac, Thomas A. D’Amico, et al. “Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 15, no. 4 (April 2017): 504–35. https://doi.org/10.6004/jnccn.2017.0050.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR, et al. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 Apr;15(4):504–35.
Ettinger, David S., et al. “Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 15, no. 4, Apr. 2017, pp. 504–35. Pubmed, doi:10.6004/jnccn.2017.0050.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR, D’Amico TA, DeCamp MM, Dilling TJ, Dobelbower M, Doebele RC, Govindan R, Gubens MA, Hennon M, Horn L, Komaki R, Lackner RP, Lanuti M, Leal TA, Leisch LJ, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 Apr;15(4):504–535.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2017
Volume
15
Issue
4
Start / End Page
504 / 535
Location
United States
Related Subject Headings
- Treatment Outcome
- Recurrence
- Prognosis
- Oncology & Carcinogenesis
- Neoplasm Metastasis
- Molecular Targeted Therapy
- Lung Neoplasms
- Immunotherapy
- Humans
- Disease Management